Latest Insider Transactions at Owens & Minor Inc (OMI)
This section provides a real-time view of insider transactions for Owens & Minor Inc (OMI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of OWENS & MINOR INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of OWENS & MINOR INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
800,000
+7.0%
|
$7,200,000
$9.75 P/Share
|
|
Mar 03
2025
|
Heath H Galloway EVP,General Counsel & CorpSecy |
BUY
Grant, award, or other acquisition
|
Direct |
69,743
+36.22%
|
-
|
|
Mar 03
2025
|
Michael Wayne Lowry SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
28,166
+18.45%
|
-
|
|
Mar 03
2025
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
BUY
Grant, award, or other acquisition
|
Direct |
123,391
+32.79%
|
-
|
|
Mar 03
2025
|
Jonathan A Leon EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
134,121
+31.95%
|
-
|
|
Mar 03
2025
|
Snehashish Sarkar |
BUY
Grant, award, or other acquisition
|
Direct |
59,013
+33.93%
|
-
|
|
Mar 03
2025
|
Edward A Pesicka President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
445,279
+27.07%
|
-
|
|
Mar 03
2025
|
Andrew G Long EVP, CEO P&HS |
BUY
Grant, award, or other acquisition
|
Direct |
134,121
+31.95%
|
-
|
|
Mar 03
2025
|
Jennifer A Stone EVP, CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
59,013
+33.7%
|
-
|
|
Mar 03
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
354,901
+3.49%
|
$3,194,109
$9.19 P/Share
|
|
Feb 28
2025
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect |
1,738,511
+15.51%
|
$15,646,599
$9.39 P/Share
|
|
Nov 21
2024
|
Jonathan A Leon EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,282
-3.88%
|
$58,102
$11.82 P/Share
|
|
Nov 18
2024
|
Snehashish Sarkar |
SELL
Open market or private sale
|
Direct |
2,055
-3.55%
|
$24,660
$12.26 P/Share
|
|
Nov 15
2024
|
Snehashish Sarkar |
SELL
Payment of exercise price or tax liability
|
Direct |
1,196
-2.02%
|
$14,352
$12.27 P/Share
|
|
Sep 23
2024
|
Jonathan A Leon EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,933
+23.98%
|
-
|
|
Aug 22
2024
|
Jonathan A Leon EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-7.45%
|
$112,500
$15.83 P/Share
|
|
Aug 08
2024
|
Andrew G Long EVP, CEO P&HS |
SELL
Bona fide gift
|
Direct |
70,898
-31.88%
|
-
|
|
Jul 01
2024
|
Michael Wayne Lowry SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
19,202
+16.62%
|
-
|
|
Jul 01
2024
|
Jonathan A Leon EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,202
+16.02%
|
-
|
|
Jun 06
2024
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
SELL
Open market or private sale
|
Direct |
20,015
-3.5%
|
$340,255
$17.48 P/Share
|
|
Jun 05
2024
|
Mark A Beck Director |
SELL
Open market or private sale
|
Direct |
9,344
-45.58%
|
$158,848
$17.25 P/Share
|
|
Jun 04
2024
|
Snehashish Sarkar |
SELL
Open market or private sale
|
Direct |
9,980
-14.44%
|
$169,660
$17.32 P/Share
|
|
Jun 03
2024
|
Alexander J Bruni EVP, CFO |
SELL
Open market or private sale
|
Direct |
10,568
-17.46%
|
$179,656
$17.76 P/Share
|
|
Jun 03
2024
|
Jennifer A Stone EVP, CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
57,078
+50.0%
|
-
|
|
May 17
2024
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,768
-3.22%
|
$33,592
$19.11 P/Share
|
|
May 17
2024
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Open market or private sale
|
Direct |
2,052
-3.61%
|
$38,988
$19.06 P/Share
|
|
May 16
2024
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Open market or private sale
|
Direct |
2,031
-3.45%
|
$40,620
$20.18 P/Share
|
|
May 15
2024
|
Jonathan A Leon EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,204
-3.78%
|
$60,876
$19.78 P/Share
|
|
May 15
2024
|
Andrew G Long EVP, CEO P&HS |
SELL
Payment of exercise price or tax liability
|
Direct |
27,372
-10.96%
|
$520,068
$19.78 P/Share
|
|
May 15
2024
|
Michael Wayne Lowry SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
2,077
-2.62%
|
$39,463
$19.78 P/Share
|
|
May 15
2024
|
Snehashish Sarkar |
SELL
Payment of exercise price or tax liability
|
Direct |
4,322
-5.89%
|
$82,118
$19.78 P/Share
|
|
May 15
2024
|
Edward A Pesicka President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
45,604
-5.7%
|
$866,476
$19.78 P/Share
|
|
May 15
2024
|
Daniel J Starck EVP, Business Excellence |
SELL
Payment of exercise price or tax liability
|
Direct |
9,446
-8.99%
|
$179,474
$19.78 P/Share
|
|
May 15
2024
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,752
-2.89%
|
$33,288
$19.78 P/Share
|
|
May 15
2024
|
Alexander J Bruni EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,290
-8.04%
|
$100,510
$19.78 P/Share
|
|
May 15
2024
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
SELL
Payment of exercise price or tax liability
|
Direct |
20,962
-12.29%
|
$398,278
$19.78 P/Share
|
|
May 09
2024
|
Mark A Beck Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,154
+35.24%
|
-
|
|
May 09
2024
|
Stephen W Klemash Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,154
+27.01%
|
-
|
|
May 09
2024
|
Teresa L. Kline Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,154
+30.67%
|
-
|
|
May 09
2024
|
Rita Johnson Mills Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,154
+30.67%
|
-
|
|
May 09
2024
|
Carissa Rollins Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,154
+30.86%
|
-
|
|
May 09
2024
|
Kenneth Gardner Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,154
+30.01%
|
-
|
|
May 09
2024
|
Robert J Henkel Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,154
+18.7%
|
-
|
|
May 01
2024
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
SELL
Open market or private sale
|
Direct |
24,094
-6.3%
|
$578,256
$24.4 P/Share
|
|
Apr 22
2024
|
Jonathan A Leon EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.58%
|
$120,000
$24.84 P/Share
|
|
Mar 15
2024
|
Edward A Pesicka President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
58,126
-6.78%
|
$1,395,024
$24.99 P/Share
|
|
Mar 15
2024
|
Michael Wayne Lowry SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
3,086
-3.75%
|
$74,064
$24.99 P/Share
|
|
Mar 15
2024
|
Andrew G Long EVP, CEO P&HS |
SELL
Payment of exercise price or tax liability
|
Direct |
22,785
-8.36%
|
$546,840
$24.99 P/Share
|
|
Mar 15
2024
|
Jonathan A Leon EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,086
-3.33%
|
$74,064
$24.99 P/Share
|
|
Mar 15
2024
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
SELL
Payment of exercise price or tax liability
|
Direct |
14,946
-7.13%
|
$358,704
$24.99 P/Share
|